Every day, across hospitals and clinics, lives quietly change with the delivery of a single document—a diagnostic report. For patients, it can redefine the future. For clinicians, it shapes the next decision. Yet for years, diagnostics in many regions—including parts of the GCC and Africa—has suffered not from lack of treatment, but from lack of timely, accurate testing.
It is within this gap that Pankaj Sohaney chose to act. As the CEO and Founder of QLABS Clinical Laboratory, he is not simply building a business—he is building a system designed to ensure that no clinical decision is made on uncertainty.
The Journey That Shaped a Visionary
Pankaj did not arrive at this point overnight. He brings more than twenty years of hands-on experience in diagnostics and healthcare expansion to everything he does at QLABS. Over the course of his career, he has worked across clinical laboratory management, oncology reference programmes, cross-border diagnostic service networks, and the layered world of public-private healthcare partnerships. Pankaj has seen the industry from the inside, its strengths and its blind spots, and he has used that knowledge to ask a simple but powerful question: what would a truly great diagnostic network look like in this part of the world?
That question became the foundation of QLABS. Pankaj co-founded the company with a clear-eyed assessment of what was missing. He saw a market that was fragmented, under-resourced, and slow to adopt the kind of precision technologies that were already transforming healthcare in other parts of the globe. Pankaj also saw an opportunity, so he rolled up his sleeves and got to work.
Building QLABS: Precision From the Ground Up
QLABS Clinical Laboratory is headquartered in Dubai and holds both CAP Accreditation and ISO 15189 Certification- two of the most rigorous quality standards in the global diagnostics industry. But for Pankaj, earning these credentials was never about ticking boxes. He pursued them because he wanted to build what he describes as a trust architecture: a system-level commitment to getting things right, every time, across every geography.
Under Pankaj’s leadership, QLABS is growing into one of the region’s most advanced multi-disciplinary reference labs. The network’s capabilities span high-complexity clinical diagnostics, cancer and oncology testing, genomics and next-generation sequencing, proteomics, molecular diagnostics, and preventive and functional medicine diagnostics. Pankaj is also expanding QLABS into home health lab services and a nationwide collection network, while simultaneously developing hospital lab management and public-private partnership models.
This is not a list of ambitions. These are programmes that Pankaj and his team are actively building and delivering- a distinction that matters deeply to him. “At QLABS, strategy and execution move together,” states Pankaj.
Trust as a Leadership Philosophy
Ask Pankaj what drives him, and he will not talk about market share or revenue targets. He will talk about trust. His leadership thesis is built on one simple idea: every diagnostic report is a clinical decision trigger. A clinician reads that report and makes a call- what medication to prescribe, whether to refer a patient for surgery, and when to tell a family that something is seriously wrong. That moment demands complete accuracy, and Pankaj holds himself and QLABS to that standard without compromise.
He believes trust in diagnostics is earned in silence. It is the quiet confidence of a doctor who orders a test from QLABS and never questions the result. It is a hospital that renews its partnership year after year because the numbers hold up. It is a patient who does not have to repeat a test in a different city because the first one was not reliable. These are the moments that Pankaj builds for, and they are far harder to achieve than any certification.
He is also direct about what quality means in this industry. It is not a differentiator. It is the minimum entry barrier. Everything above that baseline is what separates good from great; and that is the standard he is reaching for at QLABS.
“Quality is not a differentiator in diagnostics—it is the minimum entry barrier.”
Fighting Cancer With Data, Not Just Hope
Of all the areas where Pankaj is making his mark, precision oncology stands out as the most personal. He believes cancer care must shift from a reactive model to one driven by early molecular insight.
At QLABS, this vision is being realized through OnQcare—a dedicated oncology platform that integrates advanced diagnostics, clinical insights, and patient-centric care into a unified ecosystem. Through OnQcare, Pankaj is building centres of excellence focused on proactive molecular profiling, enabling detection of cancer signals long before symptoms appear.
The platform brings genomics, next-generation sequencing, and emerging proteomic insights into routine clinical workflows—making them accessible and actionable across the GCC and Africa.
“Cancer care should not begin when symptoms appear—it should begin when molecular signals emerge.”
More importantly, OnQcare connects clinicians, laboratories, and global oncology partners, ensuring diagnostics becomes a core driver of treatment decisions—not just a supporting function.
For Pankaj, this is not just innovation—it is a necessary shift toward earlier detection, smarter therapies, and better outcomes.
Partnering With Governments, Serving People
Pankaj understands that the biggest diagnostic challenges in emerging markets cannot be solved by the private sector alone. They require genuine collaboration between public institutions and private expertise. This is the space where his public-private partnership work lives, and he approaches it with a clarity that has earned him the trust of government partners and hospital systems alike.
He frames the challenge as a dual mandate: financial sustainability on one side, public health impact on the other. Getting both right at the same time is not easy. But Pankaj believes that one without the other is not really a solution. A PPP that drains public funds is not sustainable. And a commercial model that does not serve underserved populations is not meaningful. So, he structures QLABS’ partnerships to align investor expectations with health outcomes- building layered diagnostic models that work for hospitals, governments, NGOs, and academic institutions all at once.
Bold Moves, Careful Thinking
Pankaj describes his approach to leadership and entrepreneurship as calculated audacity. He does not shy away from bold decisions, but he never makes them without understanding the risks. He looks at every opportunity with the same discipline: how deep is the downside, and is the upside worth it? This habit of mind has saved QLABS from expensive mistakes and opened doors that less disciplined thinking would have missed.
He builds organisations by focusing on the aspects that actually matter: diagnostics strategy, healthcare market expansion, technology and automation, quality systems, commercial partnerships, insurance relationships, and the development of people. Pankaj believes that talent and culture are not soft assets. They are the engine of everything else. A laboratory can have the best equipment in the world and still fail without the right people running it.
This balanced approach, bold in vision and disciplined in execution, has earned QLABS industry recognition for quality and innovation. It has attracted strategic partnerships with some of the world’s leading diagnostic organisations.
More Than a Result on a Page
In the end, what Pankaj Sohaney is building at QLABS goes far beyond infrastructure. It is a system of trust—one that moves across borders, technologies, and lives with consistency and intent.
Because in diagnostics, the true measure of excellence is not the report itself, but the confidence it creates. A clinician who reads a result and acts immediately. A patient who does not need a second opinion to believe it.
That quiet, unspoken trust is not visible on paper—but it is the foundation of everything QLABS stands for. And it is the standard Pankaj continues to build toward, every single day.
